David Dingli, M.D., Ph.D.

  1. Internist
  1. Amyloidosis
  2. Monoclonal gammopathy of undetermined significance
  3. Multiple myeloma
  4. Paroxysmal nocturnal hemoglobinuria
  5. Plasma cell disorders
  6. POEMS syndrome
  7. Schnitzler syndrome
  8. Waldenstrom macroglobulinemia
  1. Bone marrow transplant
  • Multiple myeloma
  • Monoclonal gammopathy of undetermined significance (MGUS)
  • Amyloidosis
  • POEMS syndrome
  • Other plasma cell proliferative disorders
  • Waldenstrom's macroglobulinemia
  • Schnitzler syndrome
  • Paroxysmal nocturnal hemoglobinuria
  • Blood and bone marrow transplantation
  1. 2009
    Visiting ScientistMax Planck Institute for Evolutionary Biology, Plon, Germany
  2. 2007
    Visiting Scientist - Program for Evolutionary DynamicsHarvard University
  3. 2007
    Visiting Scientist - Complexo Interdisciplinar, Department of PhysicsUniversity of Lisbon
  4. 2005
    FellowHematology/Oncology Fellowship Program, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  5. 2003
    PhDMolecular Biology, Biochemistry and Molecular Biology, Programs, Mayo Graduate School, Mayo Clinic College of Medicine
  6. 2003
    PhD - Molecular BiologyMayo Graduate School, Mayo Clinic College of Medicine
  7. 2000
    ResidentMayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  8. 1997
    Senior House OfficerDepartment of Hematology, West Glasgow University Hospitals, NHS Trust, University of Glasgow, Scotland
  9. 1996
    Senior House OfficerDepartment of Internal Medicine, St. Luke's University Hospital, Guardamangia
  10. 1994
    InternshipSt. Luke's University Hospital, Guardamangia

Certifications

  1. 2000
    Internal MedicineAmerican Board of Internal Medicine

Publications

Research activities

See a description of research activities.